Relay Certified by Tritan Software; A Health Management Platform for Global Medical Operations Including the Maritime Industry

Toronto, Ontario–(Newsfile Corp. – August 13, 2021) – Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) (“Relay” or the “Company”) is pleased to announce certification by Florida-based Tritan Software Corporation (“Tritan“). Tritan’s SeaCare® is the first and only complete enterprise software solution for global medical operations within the maritime industry.

Tritan is a leading provider of Health and Safety Management software platforms. Its SeaCare® solution currently operates on approximately 95% of existing Cruise Lines, including on Celebrity Cruises, Crystal Cruises, Holland America Line, Norwegian Cruise Line, Princess Cruises, Royal Caribbean International, and Viking Ocean Cruises, and has a rapidly growing presence in the Commercial Shipping, Energy and Mining industries.

Relay becoming a Tritan SeaCare® API Certified Partner provides Relay with products and tools to support SeaCare® clients, such as the Cruise Line Industry in gathering critical data. The SeaCare® API Certified Partners program was created to vet third party vendors that aim to leverage the SeaCare® platform for integrations in order to provide them with all of the proper tools and training to develop their solutions.

The partner program includes the following:

➔ SeaCare® training on API requirements.
➔ Listing in our certified partner directory.
➔ Access to a testing environment to develop and test product integrations.

“With new variants of the COVID-19 pandemic persisting, testing in remote or mobile locations such as cruise lines and other industries, is a critical function and continuous need,” said Yoav Raiter, CEO of Relay Medical. “Relay’s Fionet Platform provides for rapid testing and tracking and is of value for those industries that must safeguard against unscheduled shutdowns. Tritan has built an impressive business supporting non-medical commercial organizations with critical health information and incident management software with its leading SeaCare® API. Fionet will be a great option for many of their clients.”

Tritan’s ability to aggregate and synchronize high-volumes of data across globally dispersed and limited connectivity locations remains unmatched in the industry. It is the leader in this respective area of expertise and utilizes several patented and proprietary methods to ensure clients receive the most value out of their data. Tritan’s extensive experience and specialized product suites specifically address the unique needs of the industry while achieving the highest value for clients and a proven return-on-investment. Its global success is due to a focus on technology innovation and 24/7 service excellence. Tritan with a rapidly growing presence in the Commercial Shipping, Energy and Mining industries. Tritan Software is a privately held corporation with headquarters in Miami, FL.

The SeaCare® API Certified Partners program was created to vet third party vendors that aim to leverage the SeaCare® platform for integrations in order to provide them with all of the proper tools and training to develop their solutions. As a certified partner Relay will receive SeaCare® training on API requirements, a listing on Tritan’s certified partner directory, and access to a testing environment to develop and test product integrations.

Relay’s Fionet Platform is an end-to-end, rapid testing and tracking solution for commercial and community-based decentralized settings including cruise liners, shipping, mining, and energy operations. Combining a fast, handheld point-of-need device connected in real time to cloud data services, the Fionet Platform handles scheduling and registration via phone app at home, on-site check-in, rapid, on-the-spot antigen testing, data integration with other testing devices, result notification, public health notification as appropriate, and anonymized data and stats for dashboards for authorized stakeholders.

Tritan’s industry leading software is designed to be easy-to-use and quick to learn in order to effectively maximize adoption and leverage the value it brings to an organization. The feature-rich and robust platform brings added capability and enhanced insights into the key operations of any organization. Furthermore, it uses the latest in advanced replication and satellite synchronization technology to ensure clients receive the highest quality of information at the highest speeds in some of the most challenging environments.

RECENT NEWS: Relay recently announced COVID-19 testing at Toronto’s 2021 National Bank Open presented by Rogers^[1]: https://bit.ly/3fTmHnh

SUBSCRIBE: For more information on Relay or to subscribe to the Company’s mail list visit: https://www.relaymedical.com/news

About Tritan Software Corporation

Tritan is the industry’s #1 provider of Health Information and Incident Management software platforms. Our extensive experience and specialized product suite provide us with an unmatched capability to address the unique needs of the industry. Our focus on technology innovation and 24/7 proactive service have contributed to our global success. Tritan currently supports approximately 95% of existing Cruise Lines with a rapidly growing presence in the Commercial Shipping, Energy and Mining industries. Tritan Software is a privately held corporation with headquarters in Miami, FL.

Website: www.tritansoftware.com

About Relay Medical Corp.

Relay Medical is a technology innovator headquartered in Toronto, Canada focused on the development of novel solutions in the diagnostics and AI data science and IoT security sectors.

Website: www.relaymedical.com

Contact:
Destine Lee
Media & Communications
Relay Medical Corp.
Office. 647-872-9982
TF. 1-844-247-6633
Media Inquiries: media@relaymedical.com
Investor Relations: investor.relations@relaymedical.com

Forward-looking Information Cautionary Statement

Except for statements of historic fact, this news release contains certain “forward-looking information” within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as “plan”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate” and other similar words, or statements that certain events or conditions “may” or “will” occur. Forward-looking statements are based on the opinions and estimates at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking statements including, but not limited to delays or uncertainties with regulatory approvals, including that of the CSE. There are uncertainties inherent in forward-looking information, including factors beyond the Company’s control. There are no assurances that the commercialization plans for the technology described in this news release will come into effect on the terms or time frame described herein. The Company undertakes no obligation to update forward-looking information if circumstances or management’s estimates or opinions should change except as required by law. The reader is cautioned not to place undue reliance on forward-looking statements. Additional information identifying risks and uncertainties that could affect financial results is contained in the Company’s filings with Canadian securities regulators, which filings are available at www.sedar.com.

^[1]https://www.relaymedical.com/newsblog/2021/8/4/5s0nkf4dw045qv3ls5c2xa00jgnfm5

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/93133